213 related articles for article (PubMed ID: 19688154)
1. Digital gangrene in systemic lupus erythematosus.
Nagai Y; Shimizu A; Suto M; Tanaka S; Yasuda M; Tago O; Hasegawa M; Ishikawa O
Acta Derm Venereol; 2009; 89(4):398-401. PubMed ID: 19688154
[TBL] [Abstract][Full Text] [Related]
2. Significant attenuation of macrovascular involvement by bosentan in a patient with diffuse cutaneous systemic sclerosis with multiple digital ulcers and gangrene.
Ichimura Y; Asano Y; Hatano M; Tamaki Z; Takekoshi T; Kogure A; Tomita M; Kawashima T; Miyazaki M; Taniguchi T; Takahashi T; Mitsui H; Sugaya M; Yao A; Kinugawa K; Sato S
Mod Rheumatol; 2011 Oct; 21(5):548-52. PubMed ID: 21547701
[TBL] [Abstract][Full Text] [Related]
3. Digital gangrene: a rare skin symptom in systemic lupus erythematosus.
Vocks E; Welcker M; Ring J
J Eur Acad Dermatol Venereol; 2000 Sep; 14(5):419-21. PubMed ID: 11305390
[TBL] [Abstract][Full Text] [Related]
4. Digital dry gangrene as a primary manifestation of systemic lupus erythematosus.
Sonkar SK; Kumar S; Atam V; Chaudhary SC
BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31818886
[TBL] [Abstract][Full Text] [Related]
5. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
6. [Extensive digital gangrene revealing late-onset systemic lupus erythematosus].
Ha-Ou-Nou FZ; Zahlane M; Benjilali L; Essaadouni L
J Med Vasc; 2017 Feb; 42(1):50-53. PubMed ID: 28705448
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment with bosentan for refractory digital ulcers in a patient with systemic lupus erythematosus.
Nagai Y; Shimizu A; Ishikawa O
J Dermatol; 2008 Jul; 35(7):447-51. PubMed ID: 18705833
[TBL] [Abstract][Full Text] [Related]
8. Large vessel occlusion and gangrene in systemic lupus erythematosus and "lupus-like" disease. A report of six cases.
Asherson RA; Derksen RH; Harris EN; Bingley PJ; Hoffbrand BI; Gharavi AE; Kater L; Hughes GR
J Rheumatol; 1986 Aug; 13(4):740-7. PubMed ID: 3772922
[TBL] [Abstract][Full Text] [Related]
9. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
10. Recurrent refractory arterial thromboembolism in a patient with anti-phospholipid antibody syndrome.
Sakakibara K; Matsumoto M; Motohashi S; Suzuki S
Intern Med; 2013; 52(10):1145-6. PubMed ID: 23676608
[No Abstract] [Full Text] [Related]
11. Digital gangrene as the initial presentation of systemic lupus erythematosus.
Adelowo O; Olaosebikan H; Ajani W; Omosebi DT
BMJ Case Rep; 2012 Nov; 2012():. PubMed ID: 23125294
[TBL] [Abstract][Full Text] [Related]
12. Digital ulcers/gangrene and immunoglobulin classes/complement fixation of anti-dsDNA in systemic lupus erythematosus patients.
Hashimoto H; Tsuda H; Takasaki Y; Fujimaki N; Suzuki M; Shiokawa Y
J Rheumatol; 1983 Oct; 10(5):727-32. PubMed ID: 6606040
[TBL] [Abstract][Full Text] [Related]
13. Arteriographic evaluation of vascular changes of the extremities in patients with systemic sclerosis.
Hasegawa M; Nagai Y; Tamura A; Ishikawa O
Br J Dermatol; 2006 Dec; 155(6):1159-64. PubMed ID: 17107383
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic and immunofluorescence study of skin lesions associated with circulating lupus anticoagulant.
Alegre VA; Winkelmann RK
J Am Acad Dermatol; 1988 Jul; 19(1 Pt 1):117-24. PubMed ID: 3136194
[TBL] [Abstract][Full Text] [Related]
15. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy-a promising treatment option for autoimmune skin ulcers: a case report.
Motta S; Monti M
Photochem Photobiol Sci; 2007 Nov; 6(11):1150-1. PubMed ID: 17973045
[TBL] [Abstract][Full Text] [Related]
17. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
18. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
19. Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis.
Marie I; Jouen F; Hellot MF; Levesque H
Br J Dermatol; 2008 Jan; 158(1):141-4. PubMed ID: 18028496
[TBL] [Abstract][Full Text] [Related]
20. Catastrophic antiphospholipid antibody syndrome in pediatric systemic lupus erythematosus.
Falcini F; Taccetti G; Ermini M; Trapani S; Matucci Cerinic M
J Rheumatol; 1997 Feb; 24(2):389-92. PubMed ID: 9035002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
